Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.73B |
| 2 |
S&P Global
SPGI
|
+$1.46B |
| 3 |
Apple
AAPL
|
+$1.27B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$957M |
| 5 |
Microsoft
MSFT
|
+$853M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.96B |
| 2 |
Tesla
TSLA
|
+$902M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$765M |
| 4 |
Sea Limited
SE
|
+$626M |
| 5 |
Canadian National Railway
CNI
|
+$560M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.15% |
| 2 | Financials | 8.45% |
| 3 | Healthcare | 7.82% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GATO
5651
DELISTED
Gatos Silver, Inc.
GATO
| $261K | ﹤0.01% |
60,288
+12,486
| +26% | +$68.7K |
|
5652
Torrid Holdings
CURV
$260M
| $260K | ﹤0.01% |
42,938
-85
| -0.2% | -$724 |
|
5653
Treace Medical Concepts
TMCI
$309M
| $260K | ﹤0.01% |
+13,739
| New | +$267K |
|
5654
ProShares Ultra Russell2000
UWM
$249M
| $260K | ﹤0.01% |
5,599
-7,519
| -57% | -$348K |
|
5655
Stereotaxis
STXS
$141M
| $259K | ﹤0.01% |
69,552
-43,181
| -38% | -$204K |
|
|
GRNA
5656
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| $258K | ﹤0.01% |
+26,807
| New | +$240K |
|
5657
CALL
Autodesk
ADSK
$52.6B
| $257K | ﹤0.01% |
1,200
-2,000
| -63% | -$461K |
|
5658
Janux Therapeutics
JANX
$967M
| $257K | ﹤0.01% |
17,934
+3,186
| +22% | +$52.1K |
|
|
SYRS
5659
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $257K | ﹤0.01% |
21,660
-27,829
| -56% | -$498K |
|
5660
XWELL
XWEL
$8.66M
| $256K | ﹤0.01% |
11,305
-2,195
| -16% | -$58.8K |
|
5661
Assembly Biosciences
ASMB
$529M
| $255K | ﹤0.01% |
10,314
+5,701
| +124% | +$122K |
|
5662
Universal Electronics
UEIC
$61.3M
| $255K | ﹤0.01% |
8,150
-10,377
| -56% | -$359K |
|
5663
Mistras Group
MG
$512M
| $254K | ﹤0.01% |
38,469
+2,477
| +7% | +$16.9K |
|
|
MKFG
5664
DELISTED
Markforged Holding Corporation
MKFG
| $253K | ﹤0.01% |
6,346
+3,124
| +97% | +$137K |
|
|
PSTX
5665
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $253K | ﹤0.01% |
56,477
-21,455
| -28% | -$96.7K |
|
|
SOGU
5666
DELISTED
AXS Short De-SPAC Daily ETF
SOGU
| $253K | ﹤0.01% |
+7,068
| New | +$269K |
|
|
UHG
5667
DELISTED
United Homes Group
UHG
| $252K | ﹤0.01% |
25,743
| – | – |
|
|
GSD
5668
DELISTED
Global Systems Dynamics Inc. Class A Common Stock
GSD
| $252K | ﹤0.01% |
+25,100
| New | +$251K |
|
|
SRT
5669
DELISTED
Startek Inc.
SRT
| $252K | ﹤0.01% |
56,965
+11,892
| +26% | +$56.1K |
|
|
VOLT
5670
DELISTED
Volt Information Sciences, Inc.
VOLT
| $251K | ﹤0.01% |
+42,008
| New | +$160K |
|
|
CARM
5671
DELISTED
Carisma Therapeutics
CARM
| $250K | ﹤0.01% |
20,683
-9,660
| -32% | -$135K |
|
5672
CorMedix
CRMD
$584M
| $250K | ﹤0.01% |
45,642
-21,717
| -32% | -$99.4K |
|
5673
Rocky Brands
RCKY
$369M
| $250K | ﹤0.01% |
+6,005
| New | +$257K |
|
5674
Algoma Steel
ASTL
$431M
| $249K | ﹤0.01% |
+22,097
| New | +$218K |
|
5675
EVgo
EVGO
$229M
| $249K | ﹤0.01% |
+19,359
| New | +$194K |
|
Similar funds
Goldman Sachs's Q1 2022 Portfolio in Review
As of Q1 2022, Goldman Sachs held 7,240 positions worth $476B, down 5.5% from $504B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs's Q1 2022 filing shows 783 new, 2,761 increased, 2,388 reduced and 700 closed positions. Its largest new stake was Shell: 8,819,856 shares worth $484M. The largest sale was Alibaba, an estimated $1.96B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q1 2022 buy was Shell: 8,819,856 shares worth $484M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $3.73B increase.
- Goldman Sachs's biggest Q1 2022 reduction was Alibaba, cutting an estimated $1.96B.
- Goldman Sachs fully exited BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares) in Q1 2022, selling an estimated $536M.
- Goldman Sachs's ten largest holdings make up 19% of its $476B portfolio in Q1 2022.
- Goldman Sachs opened 783 new positions and closed 700 in Q1 2022.
- Goldman Sachs's portfolio value fell 5.5% quarter-over-quarter to $476B.
Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.